Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF333 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TAAR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LY96 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF382 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VEPH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00551 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACSM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC283454 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNE4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GMDS-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100508631 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM135A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00824 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTN2A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RANBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on